Abraham Oomman

Greams Road, 
Chennai, TN, IN 
Greams Road, 
Chennai, TN, IN 

Overview

Abraham Oomman practices practicing medicine in Chennai, India.

His clinical expertise encompasses Transthyretin Amyloid Cardiomyopathy, Hypertension, Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), and Percutaneous Coronary Intervention (PCI).

He is actively involved in clinical research, co-authoring 44 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Greams Road, Chennai, TN, India
Other Locations
Greams Road, 600 006, Chennai, TN, India

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Open-Label Extension Study of UT-15C in Subjects With Pulmonary Arterial Hypertension- A Long-Term Follow-Up to Protocol TDE-PH-310
Open-Label Extension Study of UT-15C in Subjects With Pulmonary Arterial Hypertension- A Long-Term Follow-Up to Protocol TDE-PH-310
Enrollment Status: Completed
Publish Date: June 02, 2022
Intervention Type: Drug
Study Drug: UT-15C
Study Phase: Phase 3
A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Enrollment Status: Completed
Publish Date: February 13, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

44 Total Publications

Consensus Guidance for the Diagnosis and Management of Diabetic Kidney Disease: Executive Summary.
Consensus Guidance for the Diagnosis and Management of Diabetic Kidney Disease: Executive Summary.
Journal: The Journal of the Association of Physicians of India
Published: August 03, 2026

Frequently Asked Questions about Abraham Oomman

Is Abraham Oomman a top-rated expert for Transthyretin Amyloid Cardiomyopathy?

MediFind is an objective health platform that identifies experts based on real-world data. Abraham Oomman is classified as an Experienced expert for Transthyretin Amyloid Cardiomyopathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Abraham Oomman participate in research or clinical trials?

Yes. Abraham Oomman has published 44 articles and abstracts on conditions like Transthyretin Amyloid Cardiomyopathy. You can view a list of Abraham Oomman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Oomman's expertise for a condition
ConditionClose
        View All 17 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile